CAS 150450-53-6: 4-Quinazolinamine, N-(1,3-benzodioxol-5-ylmethyl)-6-chloro-

Description: 4-Quinazolinamine, N-(1,3-benzodioxol-5-ylmethyl)-6-chloro- is a chemical compound characterized by its quinazolinamine core, which is a bicyclic structure containing both a benzene and a pyrimidine ring. The presence of a chloro substituent at the 6-position of the quinazolinamine enhances its reactivity and potential biological activity. The N-(1,3-benzodioxol-5-ylmethyl) group indicates that the compound has a benzodioxole moiety, which is known for its role in various pharmacological activities. This compound may exhibit properties such as antimicrobial, anti-inflammatory, or anticancer effects, making it of interest in medicinal chemistry. Its molecular structure suggests potential interactions with biological targets, and its unique functional groups may influence its solubility, stability, and overall bioavailability. As with many synthetic organic compounds, understanding its characteristics, including melting point, solubility, and spectral properties, is crucial for its application in research and development. Safety data and handling precautions should also be considered due to the presence of chlorine and other reactive groups.

Formula: C₁₆H₁₂ClN₃O₂

4-Quinazolinamine, N-(1,3-benzodioxol-5-ylmethyl)-6-chloro-

CAS: 150450-53-6

• Formula: C₁₆H₁₂ClN₃O₂
• Purity: 99%
• Color and Shape: Solid
• Molecular weight: 313.73838

MBCQ

CAS: 150450-53-6

• Purity: 99.45%
• Molecular weight: 313.74g/mol

MBCQ

CAS: 150450-53-6

MBCQ is an inhibitor of cGMP-specific phosphodiesterase PDE5.

• Formula: C₁₆H₁₂ClN₃O₂
• Purity: 99.45%
• Color and Shape: Solid
• Molecular weight: 313.74

MBCQ

CAS: 150450-53-6

MBCQ is a novel compound that has been shown to be an effective treatment for …

• Formula: C₁₆H₁₂ClN₃O₂
• Purity: Min. 95%
• Molecular weight: 313.74 g/mol